GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » EV-to-FCF

Curative Biosciences (Curative Biosciences) EV-to-FCF : -0.57 (As of May. 27, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Curative Biosciences's Enterprise Value is $0.05 Mil. Curative Biosciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2018 was $-0.08 Mil. Therefore, Curative Biosciences's EV-to-FCF for today is -0.57.

The historical rank and industry rank for Curative Biosciences's EV-to-FCF or its related term are showing as below:

CBDX's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.695
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Curative Biosciences's stock price is $0.0015. Curative Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2018 was $-0.034. Therefore, Curative Biosciences's PE Ratio for today is At Loss.


Curative Biosciences EV-to-FCF Historical Data

The historical data trend for Curative Biosciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences EV-to-FCF Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.65 -94.91 -155.89 -227.05 -137.76

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Curative Biosciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curative Biosciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's EV-to-FCF falls into.



Curative Biosciences EV-to-FCF Calculation

Curative Biosciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.047/-0.083
=-0.57

Curative Biosciences's current Enterprise Value is $0.05 Mil.
Curative Biosciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curative Biosciences  (OTCPK:CBDX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Curative Biosciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0015/-0.034
=At Loss

Curative Biosciences's share price for today is $0.0015.
Curative Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.034.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Curative Biosciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biosciences (Curative Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines